Robert Lawrence Brainin's most recent trade in Champions Oncology Inc was a trade of 225,000 Option to purchase Common Stock done . Disclosure was reported to the exchange on July 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | Robert Lawrence Brainin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 225,000 | 299,163 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 150,000 | 574,163 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 100,000 | 774,163 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 100,000 | 674,163 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 62,500 | 361,663 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 62,500 | 424,163 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2021 | 23,030 | 74,163 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2021 | 19,070 | 51,133 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2021 | 14,130 | 32,063 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Robert Lawrence Brainin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2021 | 9,901 | 17,933 | - | - | Option to purchase Common Stock |